Tuesday, 5 November 2013

AstraZeneca links up with anti-cancer drug developers

UK pharmaceutical giant AstraZeneca has acquired a privately-held firm focusing on development of antibody-drug technology. AstraZeneca’s

http://bit.ly/1874NjI
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)